When Evidence Has to Lead to a Decision

I advise organisations when a public-health or life-sciences decision require complex scientific evidence. I clarify what the science supports and how any remaining uncertainty should shape the strategy.

I provide that advice independently on public health assignments and through Dig Worldwide on competitive intelligence for life sciences clients. Every project begins with the question the client needs to answer. That question sets the scope of the research, and guides subsequent work.

Network illustration of the globe

Public-Health Advice Grounded in Practice

I advise on vaccination and infectious disease questions that need scientific judgement and an understanding of how policy works in practice. I was trained in immunology and have worked directly on vaccination policy and community engagement. That experience helps me see where a scientifically sound proposal may face challenges during implementation.

That practical perspective also informs my research on measles and other vaccine-preventable diseases, including work shaped by the COVID-19 pandemic. I assess evidence on vaccine uptake and disease surveillance in the context of public confidence and the pressures of health systems.

In an assignment, I review the evidence behind proposed policies, then relate it to the conditions in which they will operate. When the findings need to reach a wider audience, I turn technical material into language that remains accurate and useful.

The resulting advice gives stakeholders a clear view of the evidence before they commit resources or defend a particular course of action. It makes clear what can be said with confidence and how the remaining uncertainty should affect the next step.

As a consultant working at Dig Worldwide, I support pharmaceutical and life sciences clients with primary competitive intelligence. The work uses direct engagement with informed sources to give clients a timely view of competitor activity and market direction, while following Dig's rigorous legal and ethical framework.

A timely view may be needed over a single congress or across a longer period as the market develops. When a client needs to prepare for a competitor response, scenario work lets the team test its options before making a move.

In immunology, the commercial significance of a development can turn on a technical detail. My scientific background helps me judge which findings are meaningful and how they may affect the competitive picture.

I then bring the source findings together into a concise assessment of what is changing and why it matters to the client's strategy. This gives our clients a strong basis for testing their assumptions and deciding whether the new intelligence calls for a response.